Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study

被引：0
|
作者：
Shuai Hao
Rongkun Luo
Wei Li
Ruhan Zhao
Tong Qi
Zichen Wang
Nan Li
Ming Liu
机构：
[1] The Third Hospital of Hebei Medical University,Department of Oncology
[2] Graduate School of Hebei Medical University,Department of Hepatobiliary and Pancreatic Surgery
[3] Third Xiangya Hospital,undefined
[4] Central South University,undefined
[5] Xiangya School of Medicine,undefined
[6] Central South University,undefined
来源：
BMC Gastroenterology | / 23卷
关键词：
Hepatocellular carcinoma (HCC); Nomogram; Overall survival(OS); Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
    Ben Khaled, Najib
    Moeller, Marie
    Jochheim, Leonie S.
    Leyh, Catherine
    Ehmer, Ursula
    Boettcher, Katrin
    Pinter, Matthias
    Balcar, Lorenz
    Scheiner, Bernhard
    Weich, Alexander
    Leicht, Hans Benno
    Zarka, Valentina
    Ye, Liangtao
    Schneider, Julia
    Piseddu, Ignazio
    Oecal, Osman
    Rau, Monika
    Sinner, Friedrich
    Venerito, Marino
    Gairing, Simon Johannes
    Foerster, Friedrich
    Mayerle, Julia
    Toni, Enrico N. De
    Geier, Andreas
    Reiter, Florian P.
    JHEP REPORTS, 2024, 6 (06)
  • [22] A real-world study of camrelizumab in the treatment of hepatocellular carcinoma.
    Zeng, Yong-Yi
    Guo, Wu-hua
    Zhang, Zhibo
    Shi, Xi
    Su, Yongjie
    Cai, Qinghe
    Peng, Jianyang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] The relationship of survival time and histopathologic diagnosis for hepatocellular carcinoma in a real-world practice
    Hung, Chien-Yuan
    Wang, Tsang-En
    Lin, Ching-Chung
    Chu, Cheng-Hsin
    Shih, Shou-Chuan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 342 - 342
  • [24] Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data
    Tian, Xi
    Xu, Wen-Hao
    Anwaier, Aihetaimujiang
    Wang, Hong-Kai
    Wan, Fang-Ning
    Cao, Da-Long
    Luo, Wen-Jie
    Shi, Guo-Hai
    Qu, Yuan-Yuan
    Zhang, Hai-Liang
    Ye, Ding-Wei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (08) : 3898 - 3911
  • [25] Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
    Hiroaki Kanzaki
    Sadahisa Ogasawara
    Tomomi Okubo
    Norio Itokawa
    Ryohei Yoshino
    Kentaro Fujimoto
    Tadayoshi Kogure
    Sae Yumita
    Takamasa Ishino
    Keita Ogawa
    Terunao Iwanaga
    Miyuki Nakagawa
    Kisako Fujiwara
    Ryuta Kojima
    Keisuke Koroki
    Masanori Inoue
    Kazufumi Kobayashi
    Naoya Kanogawa
    Soichiro Kiyono
    Masato Nakamura
    Takayuki Kondo
    Ryo Nakagawa
    Shingo Nakamoto
    Ryosuke Muroyama
    Ei Itobayashi
    Masanori Atsukawa
    Jun Kato
    Naoya Kato
    Drugs - Real World Outcomes, 2023, 10 : 513 - 520
  • [26] Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
    Kanzaki, Hiroaki
    Ogasawara, Sadahisa
    Okubo, Tomomi
    Itokawa, Norio
    Yoshino, Ryohei
    Fujimoto, Kentaro
    Kogure, Tadayoshi
    Yumita, Sae
    Ishino, Takamasa
    Ogawa, Keita
    Iwanaga, Terunao
    Nakagawa, Miyuki
    Fujiwara, Kisako
    Kojima, Ryuta
    Koroki, Keisuke
    Inoue, Masanori
    Kobayashi, Kazufumi
    Kanogawa, Naoya
    Kiyono, Soichiro
    Nakamura, Masato
    Kondo, Takayuki
    Nakagawa, Ryo
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Itobayashi, Ei
    Atsukawa, Masanori
    Kato, Jun
    Kato, Naoya
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (04) : 513 - 520
  • [27] Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study
    Zhong, Jian-Hong
    Peng, Ning-Fu
    You, Xue-Mei
    Ma, Liang
    Xiang, Xiao
    Wang, Yan-Yan
    Gong, Wen-Feng
    Wu, Fei-Xiang
    Xiang, Bang-De
    Li, Le-Qun
    ONCOTARGET, 2017, 8 (11) : 18296 - 18302
  • [28] REAL-WORLD STUDY OF ADJUVANT THERAPY AFTER COMPLETE RESECTION OF EARLY-STAGE HEPATOCELLULAR CARCINOMA
    Huang, Yue
    Peng, Hong
    Lei, Siyi
    Zhang, Qian
    Zhang, Qing
    Long, Li
    Luo, Xinhuo
    HEPATOLOGY, 2024, 80
  • [29] Establishment and validation of a survival prediction model for stage IV non-small cell lung cancer: a real-world study
    Zheng, Keao
    Zhang, Junyan
    Xu, Tingting
    Li, Fangyu
    Li, Feng
    Zeng, Jing
    Guo, Yimeng
    Hao, Zhiying
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [30] PROGNOSTIC RELEVANCE OF STAGE MIGRATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT STUDY
    Vitale, A.
    Farinati, F.
    Polacco, M.
    Burra, P.
    Trevisani, F.
    Cillo, U.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S689 - S689
12345